PPC Heads Into Earnings Down 25% on the Year, Analysts Have Chased It Lower
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Pilgrim's Pride reports Q3 results today having lost roughly a quarter of its value in 2026, with the Street's price targets following the stock down every step of the way.
The analyst community has been consistently bearish in direction, if not always in rating. UBS cut its target to $28 in early August after a weak Q2 print. BofA Securities trimmed to $30 from $37 in July. Both hold Neutral ratings. Goldman Sachs is also at Neutral, last on the record at $39 back in April. With the stock now at $27.09, down 4% on the week and 2.6% on the month, the consensus target of $33 sits about 22% above the current price. That gap has opened not because bulls are optimistic but because targets have failed to keep pace with the decline. The most recent Barclays action from May was an upgrade to Overweight with a $42 target, though that target now looks difficult to reconcile with the stock's current position.
The bear case centres on exactly what has driven the stock lower: margin pressure in the poultry segment, commodity cost volatility, and a year of earnings disappointments. The bull case rests on valuation. At roughly 10.4 times trailing earnings and an EV/EBITDA of 6.3, the stock is cheap in an absolute sense. The earnings yield ranks in the 77th percentile against the broader universe. The problem is that momentum and EPS revisions have been moving in the opposite direction. The 30- and 90-day EPS momentum scores rank in the bottom decile, and the stock's ORTEX short score has been running in the low 60s, reflecting a mix of high short interest sentiment and weak momentum signals.
Short positioning itself tells a calmer story. Short interest has declined about 13% over the past month to 2.5% of the float, a low absolute level. Borrowing costs are negligible at around 0.50%, and availability is deep at roughly 292%, meaning there is far more stock available to borrow than is currently borrowed. Shorts are quietly reducing, not building. Options positioning is similarly undramatic. The put/call ratio of 0.57 is almost exactly in line with its 20-day average, producing a z-score near zero. Neither the options market nor the lending market is showing unusual stress ahead of the print.
One structural fact worth noting: JBS N.V. holds roughly 82% of Pilgrim's Pride, and Wesley Mendonça Batista has a Schedule 13D on file, last updated in August 2026. The free float is correspondingly thin. The last earnings release in late July produced a one-day decline of nearly 9% and a five-day loss of around 8%, so the stock has a history of sharp moves on results day with limited cushion from public holders.
Today's print is less about whether PPC can mount a recovery and more about whether management can offer any credible path to margin stabilisation that justifies the wide gap between the current price and even the most cautious analyst targets.
Stocks in this article
See the live data behind this article on ORTEX.
Open PPC on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 04:35
- Data as of
- 28 Oct 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.